HER2-Positive Breast Cancer Treatment Market Insights and Forecast to 2032
January 24, 2024 10:35 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "HER2-Positive Breast Cancer - Market Insight, Epidemiology And Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. ...
Trastuzumab Biosimilars Global Market Report 2022: Focus on Product Launches by Major Players Shaping Industry
September 27, 2022 04:58 ET
|
Research and Markets
Dublin, Sept. 27, 2022 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2022: By Product, By Indication, By Distribution" report has been added to ResearchAndMarkets.com's...
The Worldwide Breast Cancer Drug Industry is Expected to Reach $27 Billion by 2026
March 09, 2022 06:58 ET
|
Research and Markets
Dublin, March 09, 2022 (GLOBE NEWSWIRE) -- The "Global Breast Cancer Drug Market (2021-2026) by Drug Type, Distribution Channel, Geography, Competitive Analysis and the Impact of Covid-19 with...
Global Herceptin (Trastuzumab) Biosimilars Pipeline Guide 2021
October 22, 2021 04:53 ET
|
Research and Markets
Dublin, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The "Herceptin (Trastuzumab) Biosimilars: Focus on Approved & Launched Biosimilars, Investigational & Research Use Biosimilars,...
HER2 Targeting Therapies Market Assessment 2021-2030 with Profiles of AstraZeneca, Boehringer Ingelheim, GSK, MacroGenics, Pfizer, Puma Biotechnology, Roche, Seagen, Triumvira Immunologics, Zymeworks
September 29, 2021 06:13 ET
|
Research and Markets
Dublin, Sept. 29, 2021 (GLOBE NEWSWIRE) -- The "HER2 Targeting Therapies Market by Target Disease Indication, Type of Molecule, Type of Therapy and Route of Administration, Key Geographical Regions:...
Global HER2+ Breast Cancer Market Will Expand to 12.1 Billion in 2030
September 21, 2021 05:43 ET
|
Research and Markets
Dublin, Sept. 21, 2021 (GLOBE NEWSWIRE) -- The "HER2+ Breast Cancer - Global Drug Forecast and Market Analysis to 2030" report has been added to ResearchAndMarkets.com's offering. Breast cancer is...
China Trastuzumab Market Report 2021-2025: With the Launch of Biosimilar Drugs, the Price of Trastuzumab May Keep Falling Which will Lead to an Increase in Sales
May 10, 2021 07:58 ET
|
Research and Markets
Dublin, May 10, 2021 (GLOBE NEWSWIRE) -- The "Investigation Report on China's Trastuzumab Market 2021-2025" report has been added to ResearchAndMarkets.com's offering. Trastuzumab is a monoclonal...
Global Trastuzumab Biosimilars Market Report 2020: Market is Expected to Decline in 2020 vs 2019 - Long-term Forecast to 2025 & 2030
May 07, 2021 06:13 ET
|
Research and Markets
Dublin, May 07, 2021 (GLOBE NEWSWIRE) -- The "Trastuzumab Biosimilars Global Market Report 2020-30: COVID-19 Growth and Change" report has been added to ResearchAndMarkets.com's offering. Major...